Table of Contents Chapter 1 Overview of Nuclear Medicine Radiopharmaceuticals 1.1 Definition of Nuclear Medicine Radiopharmaceuticals in This Report 1.2 Commercial Types of Nuclear Medicine Radiopharmaceuticals 1.2.1 Diagnostic 1.2.2 Brachytherapy 1.2.3 Other Therapeutic 1.3 Downstream Application of Nuclear Medicine Radiopharmaceuticals 1.3.1 Oncology 1.3.2 Thyroid 1.3.3 Cardiology 1.3.4 Others 1.4 Development History of Nuclear Medicine Radiopharmaceuticals 1.5 Market Status and Trend of Nuclear Medicine Radiopharmaceuticals 2013-2023 1.5.1 Global Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023 1.5.2 Regional Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Nuclear Medicine Radiopharmaceuticals 2013-2017 2.2 Sales Market of Nuclear Medicine Radiopharmaceuticals by Regions 2.2.1 Sales Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2.2.2 Sales Value of Nuclear Medicine Radiopharmaceuticals by Regions 2.3 Production Market of Nuclear Medicine Radiopharmaceuticals by Regions 2.4 Global Market Forecast of Nuclear Medicine Radiopharmaceuticals 2018-2023 2.4.1 Global Market Forecast of Nuclear Medicine Radiopharmaceuticals 2018-2023 2.4.2 Market Forecast of Nuclear Medicine Radiopharmaceuticals by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Nuclear Medicine Radiopharmaceuticals by Types 3.2 Sales Value of Nuclear Medicine Radiopharmaceuticals by Types 3.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry 4.2 Global Market Forecast of Nuclear Medicine Radiopharmaceuticals by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Nuclear Medicine Radiopharmaceuticals Market Status by Countries 5.1.1 North America Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) 5.1.2 North America Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) 5.1.3 United States Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 5.1.4 Canada Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 5.1.5 Mexico Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 5.2 North America Nuclear Medicine Radiopharmaceuticals Market Status by Manufacturers 5.3 North America Nuclear Medicine Radiopharmaceuticals Market Status by Type (2013-2017) 5.3.1 North America Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) 5.3.2 North America Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) 5.4 North America Nuclear Medicine Radiopharmaceuticals Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Nuclear Medicine Radiopharmaceuticals Market Status by Countries 6.1.1 Europe Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) 6.1.2 Europe Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) 6.1.3 Germany Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 6.1.4 UK Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 6.1.5 France Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 6.1.6 Italy Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 6.1.7 Russia Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 6.1.8 Spain Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 6.1.9 Benelux Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 6.2 Europe Nuclear Medicine Radiopharmaceuticals Market Status by Manufacturers 6.3 Europe Nuclear Medicine Radiopharmaceuticals Market Status by Type (2013-2017) 6.3.1 Europe Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) 6.3.2 Europe Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) 6.4 Europe Nuclear Medicine Radiopharmaceuticals Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Status by Countries 7.1.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) 7.1.2 Asia Pacific Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) 7.1.3 China Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 7.1.4 Japan Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 7.1.5 India Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 7.1.6 Southeast Asia Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 7.1.7 Australia Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 7.2 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Status by Manufacturers 7.3 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Status by Type (2013-2017) 7.3.1 Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) 7.3.2 Asia Pacific Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) 7.4 Asia Pacific Nuclear Medicine Radiopharmaceuticals Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Nuclear Medicine Radiopharmaceuticals Market Status by Countries 8.1.1 Latin America Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) 8.1.2 Latin America Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) 8.1.3 Brazil Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 8.1.4 Argentina Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 8.1.5 Colombia Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 8.2 Latin America Nuclear Medicine Radiopharmaceuticals Market Status by Manufacturers 8.3 Latin America Nuclear Medicine Radiopharmaceuticals Market Status by Type (2013-2017) 8.3.1 Latin America Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) 8.3.2 Latin America Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) 8.4 Latin America Nuclear Medicine Radiopharmaceuticals Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Status by Countries 9.1.1 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) 9.1.3 Middle East Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 9.1.4 Africa Nuclear Medicine Radiopharmaceuticals Market Status (2013-2017) 9.2 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Status by Manufacturers 9.3 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) 9.3.2 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) 9.4 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Nuclear Medicine Radiopharmaceuticals 10.1 Global Economy Situation and Trend Overview 10.2 Nuclear Medicine Radiopharmaceuticals Downstream Industry Situation and Trend Overview Chapter 11 Nuclear Medicine Radiopharmaceuticals Market Competition Status by Major Manufacturers 11.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers 11.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers 11.3 Basic Information of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Manufacturer 11.3.2 Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Nuclear Medicine Radiopharmaceuticals Major Manufacturers Introduction and Market Data 12.1 Mallinckrodt 12.1.1 Company profile 12.1.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.1.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt 12.2 Isorad 12.2.1 Company profile 12.2.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.2.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad 12.3 Cardinal Health 12.3.1 Company profile 12.3.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.3.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health 12.4 Jubilant 12.4.1 Company profile 12.4.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.4.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant 12.5 Medi-Radiopharma 12.5.1 Company profile 12.5.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.5.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma 12.6 Comecer 12.6.1 Company profile 12.6.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.6.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer 12.7 Jaco 12.7.1 Company profile 12.7.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.7.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco 12.8 Ciaeriar 12.8.1 Company profile 12.8.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.8.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar 12.9 Advanced Molecular-imaging Solution 12.9.1 Company profile 12.9.2 Representative Nuclear Medicine Radiopharmaceuticals Product 12.9.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution Chapter 13 Upstream and Downstream Market Analysis of Nuclear Medicine Radiopharmaceuticals 13.1 Industry Chain of Nuclear Medicine Radiopharmaceuticals 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Nuclear Medicine Radiopharmaceuticals 14.1 Cost Structure Analysis of Nuclear Medicine Radiopharmaceuticals 14.2 Raw Materials Cost Analysis of Nuclear Medicine Radiopharmaceuticals 14.3 Labor Cost Analysis of Nuclear Medicine Radiopharmaceuticals 14.4 Manufacturing Expenses Analysis of Nuclear Medicine Radiopharmaceuticals Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Diagnostic Table Advantage and Disadvantage of Brachytherapy Table Advantage and Disadvantage of Other Therapeutic Table Sales Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017 Table Sales Value of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017 Table Production Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017 Table Global Sales Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2018-2023 Table Global Sales Value of Nuclear Medicine Radiopharmaceuticals by Regions 2018-2023 Table Global Production Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2018-2023 Table Sales Volume of Nuclear Medicine Radiopharmaceuticals by Types 2013-2017 Table Sales Value of Nuclear Medicine Radiopharmaceuticals by Types 2013-2017 Table Sales Volume Forecast of Nuclear Medicine Radiopharmaceuticals by Types 2018-2023 Table Sales Value Forecast of Nuclear Medicine Radiopharmaceuticals by Types 2018-2023 Table Sales Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry 2013-2017 Table Sales Volume Forecast of Nuclear Medicine Radiopharmaceuticals by Downstream Industry 2018-2023 Table North America Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Sales Share by Countries (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Countries (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Sales Share by Type (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Revenue Share by Type (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Sales by Downstream Industry (2013-2017) Table North America Nuclear Medicine Radiopharmaceuticals Sales Share by Downstream Industry (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Sales Share by Countries (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Countries (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Sales Share by Type (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Revenue Share by Type (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Sales by Downstream Industry (2013-2017) Table Europe Nuclear Medicine Radiopharmaceuticals Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales Share by Countries (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Countries (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales Share by Type (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Revenue Share by Type (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales by Downstream Industry (2013-2017) Table Asia Pacific Nuclear Medicine Radiopharmaceuticals Sales Share by Downstream Industry (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Sales by Countries (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Sales Share by Countries (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Revenue by Countries (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Countries (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Sales Share by Type (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Revenue Share by Type (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Sales by Downstream Industry (2013-2017) Table Latin America Nuclear Medicine Radiopharmaceuticals Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Regions (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales Share by Regions (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Revenue by Regions (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Type (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales Share by Type (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Revenue by Type (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Revenue Share by Type (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales by Downstream Industry (2013-2017) Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales Share by Downstream Industry (2013-2017) Table Production Volume of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers 2013-2017 Table Production Value of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Manufacturer Table Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Manufacturer Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Mallinckrodt Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Mallinckrodt Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Isorad Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Isorad Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Cardinal Health Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Cardinal Health Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Jubilant Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Jubilant Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Medi-Radiopharma Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Medi-Radiopharma Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Comecer Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Comecer Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Jaco Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Jaco Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Ciaeriar Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Ciaeriar Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Advanced Molecular-imaging Solution Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Advanced Molecular-imaging Solution Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution 2013-2017